NGNENeurogene Inc.vs its industry peers
A metric-by-metric comparison of Neurogene Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NGNE본 종목 | $538M#6 | — | 2.5x#3 | — | -100.0%#6 | -20.2%#6 | — | -41.6%#7 | — | — | -21.5%#6 | — |
| ZVRA | $593M#1 | 10.7x#2 | 2.7x#5 | 5.6x#4 | 350.9%#1 | 178.9%#2 | -59.1%#4 | 38.2%#1 | — | — | -1.8%#5 | — |
| ANNX | — | — | — | — | — | -49.6%#8 | — | -111.1%#8 | — | — | 24.5%#4 | — |
| IRWD | $581M#2 | 4.4x#1 | — | 2.0x#1 | -15.7%#4 | 2629.5%#1 | 33.3%#1 | — | 42.6%#1 | — | 84.0%#3 | — |
| GERN | $578M#3 | — | 2.6x#4 | 2440.0x#5 | -60.2%#5 | 52.2%#3 | -28938.8%#5 | -38.2%#6 | -24.8%#3 | — | -28.6%#7 | — |
| CLYM | $565M#4 | — | 2.4x#2 | — | — | 19.0%#4 | — | -25.0%#4 | — | — | 381.9%#1 | — |
| BCAX | $564M#5 | — | 1.2x#1 | — | — | -102.9%#9 | — | -29.4%#5 | — | — | -47.6%#9 | — |
| PBYI | $531M#7 | 20.2x#3 | 3.8x#6 | 2.3x#2 | -0.9%#3 | 2.8%#5 | 16.3%#2 | 22.5%#2 | — | — | 101.6%#2 | — |
| GYRE | $530M#8 | — | 4.9x#7 | 4.5x#3 | 10.2%#2 | -44.8%#7 | 9.9%#3 | 9.2%#3 | 12.0%#2 | 3#1 | -33.4%#8 | 8.5%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice